ArticleFrontiers in oncology2021

Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma.

Joseph S Durgin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.